Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Conditions:   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other: laboratory biomarker analysis;   Other: quality-of-life assessmentSponsors:   National Cancer Institute (NCI);   North Central Cancer Treatment Group;   NSABP Foundation Inc;   Cancer and Leukemia Group B;   Southwest Oncology Group;   NCIC Clinical Trials Group;   American College of SurgeonsActive, not recruiting - verified June 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials